MBL Venture Capital Co., Ltd.

Overview

MBL Venture Capital Co., Ltd. is the investment arm of Medical & Biological Laboratories Co., Ltd., a leading Japanese biotechnology company. The firm primarily invests in seed, start-up, early, middle to later stage venture companies, including university and research institute-based ventures. It focuses on sectors such as biotechnology, life sciences, drug discovery, and regenerative medicine, often in conjunction with IT applications like bioinformatics, medical diagnostics and devices, and medical services. The firm's investment strategy encompasses a wide range of stages, from seed to pre-IPO, and it prefers to invest mainly in Japan and companies overseas. MBL Venture Capital typically seeks to have majority stakes in its portfolio companies, aiming to provide substantial support and influence over their development. Established on January 12, 2000, MBL Venture Capital is headquartered in Nagoya, Japan, with an additional office in Tokyo. The firm has a history of investing in various biotechnology and life sciences companies, contributing to the advancement of medical and healthcare innovations.

Investment Focus

• Biotechnology
• Life Sciences
• Drug Discovery
• Regenerative Medicine
• Bioinformatics
• Medical Diagnostics and Devices
• Medical Services

Portfolio Companies